When it comes to investing in dividend stocks, some investors focus mainly on yield. This can sometimes lead to investing too heavily in stocks that, while offering a high yield, could end up becoming dividend traps, whether from cutting/suspending their dividends, and/or from shares declining in value, outweighing the large payouts. Other investors focus on dividend
Stocks to buy
High-yield dividend stocks can provide investors with an extra cushion in difficult markets. After all, you continue to get paid even if share prices fall. Of course, the higher the yield the greater the risk overall. Many companies that pay above 5% are considered high-yield/high-risk. However, if you simply look for firms that have long histories of
Biotech stocks may offer some of the most explosive opportunities on the market. For one, we have millions of baby boomers demanding better care. Two, there’s substantial demand for new innovative therapies, especially with gene editing. Three, multiple heavyweight companies are hunting for new drugs to keep their pipelines fresh with patent expirations nearing. Even
Investing in the right growth stocks can help make significant gains in the stock market. Many growth stocks show an upward trend today, and they have the potential to gain momentum as the market improves. But finding the right growth stocks can be a challenge. The best ones have a solid cash flow and do
August has been a great month for investors looking for bargain stocks to buy on the dip. The S&P 500, Dow Jones Industrial Average, and the Nasdaq 100 were down 2,1%, 2.0%, and 2.4%, respectively, for the week of Aug. 14-18. Barron’s believes that September could be worse. If the past week is any indication,
In the last bull market, movement in some of the best crypto stocks was nothing less than the rally in digital assets. While crypto stocks have a high-beta, exposure at the right time can translate into quick multi-bagger returns. Several crypto stocks skyrocketed in the first half of 2023 with the surge in Bitcoin (BTC-USD)
The world may be on the mend from the grip of the global pandemic, but the consistent drumbeat for medical innovation remains as unyielding as ever. Amid this backdrop, Biotech stocks present a beacon of hope for humanity and a compelling avenue for savvy investors. Delving into the best biotech stocks offers a chance to
While high-growth stocks that are under $5 tend to be riskier than average, they can also provide aggressive investors with market-beating returns. Smaller companies in their earlier growth stages often fall into this low-price-per-share category. A stock price under $5 is commonplace for companies starting out and building their businesses. The key is identifying those
The price of Bitcoin (BTC-USD) and the broader indices continue to fall, creating an opportunity to scoop up undervalued blockchain stocks. The book value of many of these companies is tethered to the crypto market. Blockchain stocks still have a lot of potential to run, which makes them great growth picks. One advantage of investing in
Electric vehicle (EV) sales are accelerating. In fact, according to the International Energy Agency, about one in five new cars sold this year will be electric. They also noted that over 2.3 million EVs were sold in the first quarter, or 25% year-over-year and that they expect to see another 14 million of them roll
This article is an excerpt from the InvestorPlace Digest newsletter. To get news like this delivered straight to your inbox, click here. It’s been a rough month for high-growth tech stocks. The tech-heavy Nasdaq-100 index has fallen 6% since July, and many of its constituents are down even more. Fast-growing moonshots from Enphase Energy (NASDAQ:ENPH) to
The personal consumption expenditures (PCE) price index advanced 2.6% in Q2 2023, which is down from 4.1% in the first. Core PCE inflation demonstrates a persistent decline, and it excludes unpredictable fluctuations in food and energy costs for a more refined gauge to asses. Economists have highlighted heightened worker productivity levels, with Dean Baker from
For much of 2023, the AI boom has sent chip stocks to dizzying highs. It seemed like not a day went by when Nvidia (NASDAQ:NVDA) wasn’t reaching another all-time high. Even with a recent pullback, Nvidia’s stock price has increased by over 200% year to date. But some investors may balk at buying in now
Investors buy stocks hoping those investments will gain value in the long run. However, some stocks have better margins of safety than others. This has led to the rise of long-term stocks to buy. The margin of safety is a popular term among value investors who seek to buy companies that others have ignored. Once
A handful of stocks to buy under $20 can offer investors explosive returns in uncertain market conditions. The article lists names that might not immediately grab headlines, but their strategic focus and innovative progressiveness qualify them as potential multi-baggers. These three stocks to buy under $20 share a common thread of innovation and strategic alignment,
Here’s a surprise from our prime list of A-rated stocks. If you haven’t investigated flying car stocks, you’ll definitely want to add EHang (NASDAQ:EH) stock to your watch list. It’s one of the best flying car stocks available today, and a buy-and-hold position could potentially bring you sky-high returns. Based in China, EHang specializes in autonomous
As we reach the middle of August 2023, the AI rally seems to be losing steam. With this bull run showing signs of a plateau, I think it’s time to start looking for bargains in other areas of the market. In my view, we’ve hit an inflection point where market concentration is finally shifting away
The latest jobs report showed a slowing pace of hiring which will affect stock market opportunities. The July jobs report showed slowing hiring with low unemployment. The economy continues to cool, which lessens the chances that the Fed will decide to raise rates when the FOMC meets next in September. This signals investors that a
Despite the ongoing challenges, the cannabis industry has been responsive to innovation, growth, and transformation. The article lists three key players poised to capitalize on unique aspects of the cannabis market. Unlike its peers, the first stock has roots in medical cannabis, granting it a formidable foothold in global markets. From Canada to Europe and
With thousands of publicly traded securities available, it’s inevitable that more than a few names will classify as under-the-radar stocks to buy for discerning investors. I don’t say this to cast aspersions on any market expert. Rather, it’s just a fact of life: people can’t be all things at all times. Still, this framework opens